A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for Parkinson Disease
15 locations incl. Birmingham
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 40 - 85
Code: NCT06976268·Phase 2, Phase 3·Recruiting